OUR LONGITUDINAL RESEARCH:
Celebrating 50 Years of Discovery & Innovation
Fifty (50) years ago the world’s paradigm shift was small and unnoticeable. In today’s digital age of information and accelerated population growth when we fall asleep and wake up the world has completely morphed into an ever changing reality. A reality that drives the human condition and the survival of our species. When we converge population growth, its consumption demand, and available natural resources we can empirical identify a disproportionate inability to sustain life conceivably resulting in the rapid decline of human evolution.
To understand the architectural make-up of human society and what sustains it can be complex and misleading. The green industrial revolution of 1936 reformed our traditional agricultural frameworks to a centralized chemically induced infrastructure that sets the stage for all modern day food and nutritional assets. In the mist of global warming and food security breaches our nutritional value requirements have been systematically diluted with food and biological process engineering. Adversely these synthetic food and nutritional substitutes are not a sufficient value source. They inherently force the disintegration of cellular life ultimately ensuing their breakdown, followed by disease and human mortality.
At BIOFARV, in collaboration with its research parent, INSTITUTE OF BIO-CELLULAR OPTIMIZATION, our sole purpose and focus is to elevate and extend human life via cellular nutrition and cellular optimization. Within this focal point our architecture is carefully built on 3 key pillars:
1. A Genome library outlining the architecture of cellular building blocks & a register of each cell’s target specific nutrients.
2. A map(s) & critical path on how to deliver these target specific nutrients in order to achieve optimal cell absorption & bioavailability.
3. A library of formulas, protocols, & methods on how to produce cellular therapies and or nutritional products that nurture cells for optimal health and longevity.
1969-2000; Dr. Nestor Horacio Frattini and Dr. Santiago Caleque with apprentice Faustino Agüero begin the search to identify the specific cell building blocks and the ideal delivery system to nurture and supplement impaired and healthy cells.
1985-1999; Foundation for the Study of Biological Therapeutic, “FARVE” fulfilling functions Instructor with the hundreds of doctors who came to the Foundation for training in Biological Revitalization and Cellular therapy.
1986-1995; Head of clinical practice, medical training, and presentation in National Congresses of cotyledon and Gel Placental mesenchymal tissue for purposes Revitalization Mesotherapy Dermal and hair, and injectable enzyme compounds for biological medical treatment of cellulite and localized obesities.
1995-2000; Founding and Secretary General of the Board of the Argentina Society of Cell and Biological Therapeutics.
1995; 1st International Course of Cellular Therapy
1997; 5th International Congress of Biomedical Therapies
1997; International Society of therapies Citobiológicas Germany
1998-2000; Chairman Argentine Society of Therapeutic Biological Cellular
2000; Co-author “Cell Therapy and Biological – Revitalization”
1979-1990; The successful extraction and use of ultra filtrate peptides comprised of tissues and endocrine glads derived from embryonic ovine placenta stem cells.
1980-1995; Effective hydrolysis reaction through macromolecules ruptures that increase increasing and actuate the appropriate enzymes, suitable pH and temperature variations to yield a mixture of potent and sophisticated amino acids.
1980-1997; Optimal fragmentation through hydrolysis yielding a polypeptides, dipeptides and amnio acids in addition to their natural tissues which contain complex proteins (phosphor-proteins, nuclei-proteins, glycoproteins, lipoproteins and metabolic-proteins).
1981-2001; Optimal yield of supplemental building block components: phosphorus compounds, nucleic acids and nucleotides. All derived from carbohydrates and lipids, biological cofactors, trace elements and electrolytes, in addition to lysis protein derivatives.
1983-2001; Comprehensive implementation of lisado-process resulting in optimal normalization of structure, physiology and the metabolism of a particular tissue or organ.
1979-2005; Optimal cell and regeneration cocktail comprised of tissue / organ specific protein, amino acids, hydrolysates, vitamins, trace elements, minerals and herbal elements to complement and potentiate the function of the hydrolysates with the placenta stem cells.
1979-2005; Successful implementation and administration of proteolytic enzymes to reduce a range of complex proteins, polypeptides and oligopeptides peptones in order to achieve maximum reach of amino acids.
1980-Present; Maximum cell nutrition via a hydrolyzed delivery system and the culmination of DNA target specific organ building blocks for repair, regeneration and the inhibiting of cell aging.
1980-Present; Whole human bio-organism nutrition and vitalization supplements comprised of 510+ formulas sequenced by building blocks (protein & amino acids) and a potentialize (ovine embryonic stem-cell) cocktail for each organ.
1982-Present; DNA target specific cocktails for largest organ, Skin, 48 emulsion formulas for hydration, wrinkles, spots, sun protection, repair and regeneration.
1996-Present; Configuration and high effectiveness for oral aqueous administration of 408 formulas.
2018-Present; Configuration and high effectiveness for oral capsule administration of whole bio-organism anti-aging nutrition formulas.
2019-Present; Configuration and high effectiveness for oral capsule administration of fat density (trans & saturated deposits) distribution and expel formulas.
PUBLICATION OVERVIEW
1Circa 1980 - 1989
Center for Cellular Therapy & Cytoplasmic Information and Library Archive; Volume 1, 1976-1982, Cytoplasmic Biology (1982).
Foundation for the Study of Biological Therapeutic, “FARVE” fulfilling functions Instructor with the hundreds of doctors who came to the Foundation for training in Biological Revitalization and Cellular therapy; (1985).
Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli; 2n.d Simposium Cellular Therapy, (1988).
2Circa 1990 - 1999
Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli, Dr. Josue A. Muchnik; immunological tolerance to massive and repeated implants: effects on aging part 1, (1993).
Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli, Dr. Josue A. Muchnik; immunological tolerance to massive and repeated implants: effects on aging part 2, clinical trials, (1993).
Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli, Dr. Nestor E. Bravo, Irene A. Funai; Advances en plastic surgery and repair in the pre and post surgical procedures with molecular nutrition, (1994).
Dr. Santiago Caleque; brief clinical overview in the following cellular and molecular therapies via the use of thymus glands and placenta cotyledon tissues for the mediation of biological conditions, (1996).
Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli; a 13 part system outlining molecular therapies specific to organ tissues and their optimal function, (1997).
Dr. Santiago Caleque, Dr. Aaron Erenfryd; cellular and organ therapies via macromolecular nutrition, (1997).
Dr. Santiago Caleque; pluripotent cells revitalization via macromolecular tissue therapies, (1998).
Dr. Santiago Caleque; therapy protocols in molecular tissues, (1999).
3Circa 2000 - Present
Dr. Santiago Caleque, Dr. Gabriel Faraj Cualli; blastema tissues, the fundamentals of mesenchymal stem cells (2000).
Dr. Santiago Caleque, Dr. Ruben O. Muhlberger, Dr. Eduardo Arganaras; prophylaxis for aging and metabolic conditions via molecular tissue therapies, (2000).
Dr. Hayde Losa; delivery absorption of hydrolyzed molecular tissue cocktails, (2009).
Configuration and high effectiveness for oral aqueous administration of 408 formulas via Hydrolization for cell nutrition, repair, regeneration and anti-aging (1996-Present).
Manual for configuration and implementation of high effectiveness for oral capsule administration of whole bio-organism anti-aging nutrition formulas (2018-Present).
Manual configuration and implementation of high effectiveness for oral capsule administration of fat density (trans & saturated deposits) distribution and expel formulas (2019-Present).